|
Inflammation measures ( = 295) | |
CRP (mg/L), median iqr | 1.1 2.0 |
IL-6 (pg/mL), median iqr | 2.0 1.5 |
TNFα (pg/mL), mean sd | 9.0 2.9 |
PAI-1 (ng/mL), mean sd | 47 26 |
Adiponectin (μg/mL), median iqr | 9.0 7.7 |
|
Insulin sensitivity/resistance ( = 293) | |
Glucose (mg/dL), mean sd | 95 8 |
Diabetes status, (%) | |
Normal (glucose < 100) | 219 (75) |
Prediabetic (glucose 100–125) | 74 (25) |
HOMA, median iqr | 1.1 0.8 |
QUICKI, mean sd | 0.37 0.03 |
|
Microvascular measures ( = 254) | |
Capillary density: at rest (# capillaries per mm2), mean sd | 37 8 |
Capillary density: venous occlusion (# capillaries per mm2), mean sd | 55 12 |
|
Urine albumin excretion ( = 250) | |
Albumin (μg/mL), median iqr | 1.9 2.6 |
Albumin (μg/min), median iqr | 1.4 1.9 |
Albumin-to-creatinine ratio (ACR, mg/g), median iqr | 2.8 3.8 |
|
Endothelial measures ( = 271) | |
FBF postischemic, mean sd | 27 9 |
FBF ratio (postischemic to baseline), mean sd | 9 3 |
FBF increase from baseline to postischemic (%), mean sd | 795 330 |
FVR postischemic, median iqr | 2.9 1.4 |
FVR ratio (baseline to postischemic), median iqr | 0.12 0.07 |
FVR decrease from baseline to postischemic (%), mean sd | 87 6 |
|